
|Articles|November 1, 2003
Understanding Hair Development
Chicago - New findings from ongoing research aiming to delineate the mechanism of action of eflornithine hydrochloride 13.9 percent cream (Vaniqa) in the treatment of pseudofolliculitis barbae (PFB) indicate that one pathway may involve drug-induced actin disarray in the outer root sheath with a subsequent effect on axial fiber development, said Steve Chow, M.S., to attendees at Ethnic Hair and Skin: New Directions in Research.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















